Literature DB >> 22555681

Trends in outcome and hospitalization charges of adult patients admitted with botulism in the United States.

Nizar Souayah1, Lubna Shafiq Mehyar, Hafiz M R Khan, Hussam A Yacoub, Zaid Abed Al-Kariem A Al-Qudah, Abu Nasar, Zubeda Begum Sheikh, Leila Maybodi, Adnan I Qureshi.   

Abstract

BACKGROUND: To assess the impact of new therapeutic strategies on outcomes and hospitalization charges among adult patients with botulism in the United States.
METHODS: We determined in-hospital outcomes and charges for patients with botulism hospitalized in 1993-1994 and compared them with those observed among patients hospitalized in 2006-2007. Mortality, length of stay, and hospitalization charges were calculated. Age, sex, race, ethnicity, and discharge status were also reported.
RESULTS: There were 66 and 132 admissions of adult patients with botulism in 1993-1994 and 2006-2007, respectively. Men predominance was observed in 2006-2007 compared to women predominance during the 1993-1994 time period. There was no significant difference in the average length of stay and in-hospital mortality rate between the two groups studied. However, in the 2006-2007 group, there was a significant increase in the mean hospitalization charges (USD 126,092 ± 120,535 vs. USD 83,623 ± 82,084; p = 0.0107) and in the proportion of patients requiring mechanical ventilation when compared to 1993-1994 (34 vs. 13.6%; p < 0.0001).
CONCLUSION: Botulism continues to be an infrequent cause of hospitalization, with a significant increase in the average hospitalization charges in 2006-2007 when compared to 1993-1994, despite a nonsignificant change in the mortality rate and average length of hospitalization.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22555681     DOI: 10.1159/000336354

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  3 in total

1.  Symptomatic treatment of botulism with a clinically approved small molecule.

Authors:  Edwin Vazquez-Cintron; James Machamer; Celinia Ondeck; Kathleen Pagarigan; Brittany Winner; Paige Bodner; Kyle Kelly; M Ross Pennington; Patrick McNutt
Journal:  JCI Insight       Date:  2020-01-30

2.  Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.

Authors:  James B Machamer; Edwin J Vazquez-Cintron; Sean W O'Brien; Kyle E Kelly; Amber C Altvater; Kathleen T Pagarigan; Parker B Dubee; Celinia A Ondeck; Patrick M McNutt
Journal:  Mol Med       Date:  2022-06-03       Impact factor: 6.376

3.  Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product.

Authors:  Deborah M Anderson; Veena R Kumar; Diana L Arper; Eliza Kruger; S Pinar Bilir; Jason S Richardson
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.